1. Home
  2. CTRE vs GRFS Comparison

CTRE vs GRFS Comparison

Compare CTRE & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRE
  • GRFS
  • Stock Information
  • Founded
  • CTRE 2013
  • GRFS 1940
  • Country
  • CTRE United States
  • GRFS Spain
  • Employees
  • CTRE N/A
  • GRFS N/A
  • Industry
  • CTRE Real Estate Investment Trusts
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTRE Real Estate
  • GRFS Health Care
  • Exchange
  • CTRE Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • CTRE 7.5B
  • GRFS 6.6B
  • IPO Year
  • CTRE N/A
  • GRFS 2006
  • Fundamental
  • Price
  • CTRE $35.55
  • GRFS $9.95
  • Analyst Decision
  • CTRE Buy
  • GRFS Hold
  • Analyst Count
  • CTRE 5
  • GRFS 1
  • Target Price
  • CTRE $35.00
  • GRFS $10.30
  • AVG Volume (30 Days)
  • CTRE 2.3M
  • GRFS 553.6K
  • Earning Date
  • CTRE 10-28-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • CTRE 3.78%
  • GRFS 1.43%
  • EPS Growth
  • CTRE 108.23
  • GRFS 132.60
  • EPS
  • CTRE 1.21
  • GRFS 0.53
  • Revenue
  • CTRE $373,415,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • CTRE $18.92
  • GRFS $5.61
  • Revenue Next Year
  • CTRE $26.91
  • GRFS $6.70
  • P/E Ratio
  • CTRE $29.37
  • GRFS $25.25
  • Revenue Growth
  • CTRE 50.83
  • GRFS 9.32
  • 52 Week Low
  • CTRE $24.79
  • GRFS $6.19
  • 52 Week High
  • CTRE $35.68
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • CTRE 63.78
  • GRFS 51.32
  • Support Level
  • CTRE $34.07
  • GRFS $9.88
  • Resistance Level
  • CTRE $35.28
  • GRFS $10.23
  • Average True Range (ATR)
  • CTRE 0.63
  • GRFS 0.18
  • MACD
  • CTRE 0.05
  • GRFS 0.03
  • Stochastic Oscillator
  • CTRE 91.39
  • GRFS 54.10

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: